Friday, 18 Sep 2026
Empowering Chinese Pharma’s Global Expansion
Contact US
Home
About US
Policy Hub
Categories
Drug
Company
Deals
Policy / Regulatory
Medical Device
R&D
Legal / IP
Digital
Privacy Policy
Contact US
My News
Cancer
Clinical trial approval / initiation
Product approvals
Clinical trial results
Finance
ADC / XDC
Finanical Reports
Biotech
Market approval filings
PD-1/L1
Read History
Search
Pages
Home
Blog Index
POLICY HUB
Contact Us
Personalized
Read History
Categories
Company
Drug
Policy / Regulatory
Medical Device
R&D
Digital
Legal / IP
Deals
Have an existing account?
Sign In
Follow US
Fineline Cube
Follow:
14423
Articles
Company
Drug
SciClone and Menarini Submit NDA for Vaborem in China
January 17, 2025
Company
Deals
Servier and Google Cloud Extend Partnership to Advance AI in Drug Development
January 17, 2025
Company
Deals
Cathay Biotech Plans $901M Private Placement to Boost Bio-Based Materials
January 17, 2025
Company
Deals
Simcere Licenses Fermion’s AI-Enabled Painkiller FZ002-037
January 17, 2025
Company
Medical Device
Boston Scientific’s FARAPULSE and WATCHMAN FLX Studies Show Positive Results
January 17, 2025
Company
Drug
Asieris’ USP1 Inhibitor APL-2302 Cleared for Clinical Trials
January 17, 2025
Company
Drug
Zhejiang Huahai’s HB0056 Approved for US Phase I Asthma Trial
January 17, 2025
Company
Drug
Hengrui’s HER2-Targeted ADC and Antibody Drug Combo Approved for Trials
January 17, 2025
Company
Drug
CSPC’s SYS 6043 Receives FDA Approval for Clinical Trials
January 17, 2025
Company
Drug
Innovent’s Limertinib Wins NMPA Approval for NSCLC Treatment
January 17, 2025
Company
ConjuStar Completes $15 Million Pre-A+ Financing Round
January 17, 2025
Company
Deals
Bio-Thera Solutions Licenses BAT2206 to World Medicine for Turkey
February 28, 2025
1
2
…
468
469
470
471
472
…
1,201
1,202
Welcome to Fineline Cube!
Username or Email Address
Password
Remember me
Lost your password?